If you have one of the 1.5 million children who suffer with peanut allergies (or struggle yourself), things might be looking up. DBV Technologies has been working on a groundbreaking patch that helps to lessen the severity of this allergy and data was just released, showing that it’s working.
Here’s the main takeaway: the company shared at American Academy of Allergy, Asthma and Immunology conference that 83 percent of children ages 6 to 11 who took part in the trial could eat 1000 milligrams of peanuts without having an allergic reaction after wearing a patch for three years.
Talk about progress!
Furthermore, that’s more than ten times the amount of peanuts the kids were able to have before the study started.
The patch works through a system called “epicutaneous immunotherapy” where both sides is sprayed with peanut protein that makes its way into your system upon contact. Being delivered this way, it never makes it to the blood stream – which would cause the reaction that you would be trying to avoid.
The company is working to create similar patches for other common allergies such as egg and celiac disease, and we’re pretty stoked to see what the future holds.